Navigation Links
Capillus® Laser Therapy Caps Receive FDA Clearance For Over-The-Counter Use
Date:2/16/2017

Capillus®, LLC, a medical device manufacturer focused on providing customers with the best products in treatment for hair loss, announced today that the U.S. Food and Drug Administration (FDA) has cleared its at-home laser therapy caps for over-the-counter (OTC) treatment of hair loss, as well as its clinical-use standing laser unit, making it the only such device legally available without a prescription in the United States.

Previously, the Capillus82™ and Capillus202™ home-use laser therapy caps and the Capillus272 OfficePro™ standing unit for clinical use were only available on order of a healthcare professional through Capillus’ physician network. This new FDA 510(k) clearance now allows individuals suffering from hereditary hair loss to also purchase the devices through online retailers and salons. Capillus laser therapy devices are now available on Amazon.com and select salons and retailers, in addition to the company’s website, http://www.capillus.com.

About Capillus Home-Use Laser Therapy Caps
Capillus laser devices use safe, low level lasers to energize hair follicles and spur new, natural hair growth through photobiomodulation. The lightweight Capillus laser caps are discreet and allow those with hereditary hair loss to enjoy the proven benefits of laser hair restoration on their own schedule without having to visit a physician’s office. All are designed to be worn on the inside of the provided Capillus hat or an ordinary baseball cap, eliminating the embarrassment that can be associated with other hair restoration devices. The routine is as simple as wearing the cap for 30 minutes, every other day.

About Capillus Clinical-Use Laser Therapy Unit
The Capillus272 OfficePro offers users the flexibility to undergo laser therapy at physicians’ practices and salons before purchasing a device of their own. Salons can now offer this treatment to their regular clients with thinning hair as an additional service.

“This is an exciting development for the millions of people who suffer from hair loss, and we are thrilled to be able to offer them access to a safe and effective over-the-counter laser therapy treatment solution,” said Carlos Pina, chief executive officer, Capillus, LLC.

Capillus laser therapy has been clinically proven effective through an independently reviewed trial that showed success in over 95 percent of active clinical study participants. Participants showed an average of 51 percent more hair within 17 weeks.

The announcement of the FDA 510(k) Clearance (K163170) comes on the heels of Capillus’ receipt of a Class II Medical Device License by Health Canada late last year, as well as its ISO 13485:2003 certification, which was received through the Medical Device Single Audit Program (MDSAP) pilot and ensures Capillus meets current Good Manufacturing Practices set by the FDA.

Capillus is cleared for use by the U.S. FDA for both males and females.

If you are a salon or other retail owner interested in offering Capillus laser therapy devices for hair regrowth to your customers, please call 786-888-6249.

To learn more about laser hair restoration with Capillus, please visit https://www.capillus.com/ or call toll-free 1-888-272-9599.

ABOUT CAPILLUS, LLC
Capillus, LLC is a Miami-based medical device manufacturer & marketer of solutions for hair loss. Founded in 2012, the company is a resource for those battling hair loss. Capillus, LLC serves the physician and the consumer market with medical laser devices (Capillus82, Capillus202, Capillus272 Pro, & Capillus272 OfficePro) and cosmetic products which include a line of clinical hair care products and keratin hair fibers. The company also connects patients to hair transplant surgeons & dermatologists for both surgical & non-invasive treatment options. 

Capillus was founded in October 2012 and received its first FDA 510(k) clearance in January of 2015.  Capillus has been manufacturing its medical laser devices since January 2015. The company moved to its present day 25,000 square foot location in the area of Doral to expand its manufacturing facilities in June of 2015 and has been experiencing steady growth with a total of 7 FDA 510(k) clearances for its seven laser therapy models, including both genders and OTC.

Building on its mission to provide customers with the best products in treatment of hair loss, all Capillus products cater to both women & men with thinning hair or at risk for thinning hair, a condition that affects up to 50% of adult women and 80% of adult men.

Read the full story at http://www.prweb.com/releases/2017/02/prweb14079001.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Capillus® and National Hair Loss Team to Promote Breast Cancer Awareness
2. Capillus® Laser Caps Are First to Receive FDA Clearance for Male and Female Hair Loss Treatment
3. New Treatment for Excessive Underarm Sweat Now Available at SOMA Skin & Laser in Millburn, NJ
4. Femtosecond Lasers for Cataract Surgery Market
5. Laser Cutting, Drilling, Marking and Engraving Market Worth $3.77 Billion By 2018
6. Laser Eye Center Promotes Vision Education for Diabetes Awareness Month
7. Peter Baker: 25 Years Dedicated to Keeping LIA at the Forefront of Laser Safety & Applications
8. Atlanta LASIK Surgery Center Acquires Latest in Laser Technology
9. North Shore-LIJ Physician Is First to Use Thulium Laser for Prostate Surgeries
10. 4-year-old is First Pediatric Patient in U.S. to Undergo Laser Cataract Removal
11. Last Quarter Witnessing More Treatments at Body Oasis Laser Aesthetics Medical Spa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2019)... SCOTCH PLAINS, N.J. (PRWEB) , ... September 18, ... ... Michael L. Scagnelli, DMD for the fourth consecutive year. Dr. Scagnelli specializes in ... Matawan-based practice was established in the 1940’s and has been delivering quality dental ...
(Date:9/17/2019)... ... 17, 2019 , ... Six Consulting Inc. (SIX) recently announced ... – specifically golden retrievers - through innovative cancer prevention medicine. A national survey ... out of five retrievers in the United States will die from a particular ...
(Date:9/17/2019)... ... ... Lubin Austermuehle, P.C. will be one of the sponsors of GRIN2B ... Found Kitchen and Social House in Evanston on Monday, October 7 from 6 p.m. ... rare condition that results from changes to the GRIN2B gene. The GRIN2B gene is ...
(Date:9/17/2019)... LYNDHURST, N.J. (PRWEB) , ... September 17, 2019 ... ... in a wide array of services, welcomes Dr. Yevgeniya (Jenny) Gartshteyn to their ... University Medical Center, where she previously held the Clinical Appointment of Assistant Professor ...
(Date:9/11/2019)... ... September 12, 2019 , ... “Heart Seizures”: a useful source of ... disease as he hopes to prevent anyone from having it and to help those ... Saltwick, a writer who was diagnosed with coronary artery disease. Predicted to experience another ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... ... September 13, 2019 , ... St. Joseph’s Hospital, Robins ... the structural topping out of the St. Joseph’s Hospital patient tower expansion located ... new six-story patient tower that will house a two-story lobby, waiting and on-call ...
(Date:9/12/2019)... ... ... Stratosphere Networks will sponsor GRIN2B Foundation’s first cocktail reception fundraiser, ... at Found Kitchen and Social House in Evanston from 6 p.m. to 9 p.m. ... is a gene on the short arm of the 12th chromosome and is part ...
(Date:9/11/2019)... ... 12, 2019 , ... Understanding the Drug Supply Chain Security ... Sept. 26, 2019, 1:30-3:00 p.m. EDT, https://www.fdanews.com/understanding-the-dscsa , Need to comply ... clear on nuances of the guidelines regulating the drug supply chain? , ...
Breaking Medicine Technology: